Literature DB >> 12112543

The impact of second opinion surgical pathology on the practice of head and neck surgery: a decade experience at a large referral hospital.

William H Westra1, Joseph D Kronz, David W Eisele.   

Abstract

BACKGROUND: A second review of histopathologic diagnoses is a quality assurance practice that helps expose diagnostic errors and guide management of patients being referred from outside hospitals. Identification of anatomic regions and specimen types that are prone to diagnostic error will be helpful in guiding policy decisions regarding mandatory second opinion surgical pathology.
METHODS: All available outside pathology reports were retrieved for patients referred to The Johns Hopkins Hospital Department of Otolaryngology-Head and Neck Surgery between January 1, 1990, and January 1, 2000. The outside diagnosis was compared with diagnosis rendered at the referral hospital. A discrepant diagnosis was regarded as any change resulting in a significant modification in therapy or prognosis.
RESULTS: Of the 814 cases reviewed, the second opinion surgical pathology diagnosis resulted in 54 (7%) changed diagnoses. Of the changed diagnosis, 13 (24%) involved a change from a benign to a malignant diagnosis; 8 (15%) involved a change from a malignant to a benign diagnosis; and 33 (61%) involved a change in tumor classification. Follow-up information supported the second opinion diagnosis in 41 of 43 cases (95%).
CONCLUSIONS: In a consequential number of cases, second opinion surgical pathology results in major therapeutic and prognostic modifications for patients sent to large referral hospitals for head and neck oncologic surgery. Copyright 2002 Wiley Periodicals, Inc. Head Neck

Entities:  

Mesh:

Year:  2002        PMID: 12112543     DOI: 10.1002/hed.10105

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  15 in total

Review 1.  High-risk non-melanoma skin cancer of the head and neck.

Authors:  Stephen Y Lai; Randal S Weber
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.075

2.  Teledentistry: distant diagnosis of oral disease using e-mails.

Authors:  Cassius C Torres-Pereira; Imara de Almeida Castro Morosini; Renata Seleme Possebon; Allan Fernando Giovanini; Marcelo Carlos Bortoluzzi; Jair Carneiro Leão; Cleto Mariosvaldo Piazzetta
Journal:  Telemed J E Health       Date:  2013-01-28       Impact factor: 3.536

3.  Double reporting and second opinion in head and neck pathology.

Authors:  Julia A Woolgar; Asterios Triantafyllou; Lester D R Thompson; Jennifer L Hunt; James S Lewis; Michelle D Williams; Antonio Cardesa; Alessandra Rinaldo; Leon Barnes; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; William H Westra; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-17       Impact factor: 2.503

Review 4.  Recurrent salivary gland cancer.

Authors:  M Boyd Gillespie; W Greer Albergotti; David W Eisele
Journal:  Curr Treat Options Oncol       Date:  2012-03

5.  A Comparative Study of the Perspectives of General and Oral and Maxillofacial Pathologists about the Rate and Value of Second Referral in Assessment of Oral and Maxillofacial Pathologic Lesions.

Authors:  Sayed Mohammad Razavi; Alireza Liaghatdar; Neda Kargahi
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

6.  Coherent Raman Scattering Microscopy for Evaluation of Head and Neck Carcinoma.

Authors:  Rebecca C Hoesli; Daniel A Orringer; Jonathan B McHugh; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-11       Impact factor: 3.497

7.  Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region.

Authors:  Antoine Lurkin; Francoise Ducimetière; Dominique Ranchère Vince; Anne-Valérie Decouvelaere; Dominic Cellier; François N Gilly; Dimitri Salameire; Pierre Biron; Guy de Laroche; Jean Yves Blay; Isabelle Ray-Coquard
Journal:  BMC Cancer       Date:  2010-04-19       Impact factor: 4.430

8.  Salivary type tumors seen in consultation.

Authors:  Simion I Chiosea; Robert Peel; E Leon Barnes; Raja R Seethala
Journal:  Virchows Arch       Date:  2009-03-07       Impact factor: 4.064

9.  Salivary gland tumors in Turkey: demographic features and histopathological distribution of 510 patients.

Authors:  Yusuf Kızıl; Utku Aydil; Ozgür Ekinci; Alper Dilci; Ahmet Köybaşıoğlu; Mehmet Düzlü; Erdoğan Inal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-11-10

10.  Low Molecular Weight Cytokeratin Immunostaining for Extrafollicular Reticulum Cells is an Effective Means of Separating Salivary Gland Tumor-Associated Lymphoid Proliferation from True Lymph Node Involvement.

Authors:  Elizabeth M Kurian; Rodney Miller; Anne L Mclean-Holden; Bahram R Oliai; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2019-09-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.